MeiraGTx

New York, United States

MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.

$100.0M raised

Apr 2026

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has MeiraGTx raised?

MeiraGTx has raised $100.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.

Who are MeiraGTx's investors?

MeiraGTx's investors include Sanofi, Perceptive Advisors, ATW Partners, AlbionVC, UCL Technology Fund.

Where is MeiraGTx headquartered?

MeiraGTx is headquartered in New York, United States.

What does MeiraGTx do?

MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.

What stage is MeiraGTx at?

MeiraGTx is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 16, 2026.

MLA

"MeiraGTx — Funding & Investors." VCBacked, April 16, 2026, https://www.vcbacked.co/company/meiragtx. Accessed July 4, 2026.

APA

VCBacked. (2026). MeiraGTx — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/meiragtx

Wikipedia (cite web)

{{cite web |title=MeiraGTx — Funding & Investors |url=https://www.vcbacked.co/company/meiragtx |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 16, 2026.